Coronavirus and Parkinson’s: what you need to know
Author: Saskia MairPublished: 19 March 2020
Prep: Cook: Serves:
As the world confronts the coronavirus pandemic, we ask how the societal impact of the disease – and the virus itself – could affect people living with Parkinson’s
The coronavirus disease (Covid-19) – a respiratory virus, which affects the lungs and airways – has now been reported in more than 100 countries around the world.
Symptoms include a fever and a continuous cough – and can take up to 14 days to appear following exposure to the virus. While many people with the illness will have milder symptoms, similar to a cold, others can experience more severe symptoms and disease-related complications. The World Health Organisation declared a pandemic on 11 March 2020.
So, what does this mean for people with Parkinson’s? Because the disease is new and has only affected humans since the end of last year, scientists don’t know exactly how it affects people with the condition.
The UK government has published a list of those at higher risk of severe illness from Covid-19 which includes all people over the age of 70, and people under 70 with a chronic neurological condition such as Parkinson’s. This means people with the condition are considered at a higher risk of having severe symptoms or complications if they are infected by the virus.
Russell Patten, secretary general of the European Parkinson’s Disease Association (EPDA), said: “These are challenging, worrying and frustrating times for everyone in the world – particularly European people with Parkinson’s and their families as the continent is seemingly at the centre of the coronavirus crisis. Borders are closing down at furious speed and movement everywhere is restricted.
“In such difficult circumstances, we must stay strong and grow resilient as a community. Parkinson’s organisations and individuals around the globe are offering support and hope to the masses, mostly online via extra free resources and information to help us stay fit, energised and strong (mentally and physically) while we stay indoors and as safe as possible. We at the EPDA are busily preparing some exciting home-based exercise resources that we’ll share in the next week or so, so watch this space.
“Now is not the time to retreat inwardly; we must tackle anxiety and isolation at home by communicating in new ways.”
The Parkinson’s community is being affected by worldwide cancellations, including that of the Parkinson’s Vision 2020 conference, which was due to take place on 17 and 18 April in Leicester, UK.
The Conference Volunteer Team said: “Although we are bitterly disappointed that the conference is not going ahead as planned, the momentum behind highlighting the issues for those of us living with YOPD has been driven forward by the support of this conference through social media, media and other channels.”
Parkinson’s UK is advising the organisers of local Parkinson’s groups to stop local activities as a precautionary measure. Parkinson Canada said that in-person support meetings had been cancelled until further notice, and US charity, Parkinson’s Foundation, has announced that all in-person events until the end of May will be postponed, although they will continue to run online webinars.
For up-to-date information about Covid-19 please get in touch with your healthcare authorities and check updates provided by reliable Parkinson’s organisations.
How have you been affected by the coronavirus?
We will be doing all we can to share useful information about Covid-19 with you as the situation develops – and we need your help. To share your experience or tell us the topics you want Parkinson’s Life to cover during the pandemic, please leave a comment or email firstname.lastname@example.org.
For more information about Covid-19 please visit the EPDA website.
EPDA ExerciseCast: How to stay active during the coronavirus crisis
Josefa Domingos on how to stay active in lockdown
2 days ago
Heart problems linked to dementia risk in Parkinson’s disease, say researchers
Researchers at the University of Turin, Italy, have identified that Parkinson’s-related cardiovascular problems may increase a patient’s risk of developing dementia within five years. According to the study, it is estimated that more than half of people with Parkinson’s experience an impairment of the autonomic nervous system – which helps to regulate bodily functions such as blood pressure, body temperature, respiration and heart rate. The researchers investigated the effects of this impairment on key functional Parkinson’s outcomes – including dementia, falls and postural instability – by observing 65 patients at the university’s movement disorders centre and following up after five years. Evaluations throughout the study assessed patients’ cognitive function, automatic symptoms and other motor and non-motor features. In the findings, which were published in the ‘Journal of Neurology’, the researchers noted that worse cardiovascular assessment scores were “associated with a sevenfold higher risk of developing dementia”.
A “revolutionary” step in stem cell therapy for Parkinson’s disease?
Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.
Could frequent nightmares be an early sign of Parkinson’s disease?
A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”